Alivus Life Sciences Schedules Q4 FY2025-26 Earnings Call for May 15, 2026
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has announced an earnings call for Q4 FY2025-26 and full-year FY2025-26 financial results, scheduled for May 15, 2026, from 8:30 a.m. to 9:30 a.m. IST. The call is accessible via universal dial-in numbers for India and international toll-free/toll numbers across countries including the USA, UK, Singapore, and Australia. For clarifications, participants may contact Diwakar Pingle or Runjhun Jain via the provided email and phone details.
*this image is generated using AI for illustrative purposes only.
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has announced an earnings call to present its financial performance for Q4 FY2025-26 and the full fiscal year FY2025-26. The announcement was formally communicated to BSE Ltd. and the National Stock Exchange of India Ltd. on May 08, 2026, by Company Secretary & Compliance Officer Rudalf Corriea.
Earnings Call Details
The earnings call is scheduled for Friday, May 15, 2026, from 8:30 a.m. to 9:30 a.m. (IST). Participants may join the call using the dial-in numbers provided below.
| Parameter: | Details |
|---|---|
| Date: | Friday, May 15, 2026 |
| Time: | 8:30 a.m. – 9:30 a.m. (IST) |
| Universal Dial-in (India): | +91 22 6280 1564 / +91 22 7115 8394 |
International Access Numbers
Participants joining from outside India can use the following international toll-free and international toll numbers:
International Toll-Free:
| Country: | Number |
|---|---|
| Australia: | 1800053698 |
| Canada: | 01180014243444 |
| China: | 4008428405 |
| Hong Kong: | 8009644448 |
| Italy: | 0080014243444 |
| Japan: | 00531161110 |
| Singapore: | 8001012045 |
| South Korea: | 00180014243444 |
| UK: | 08081011573 |
| USA: | 18667462133 |
International Toll:
| Country: | Number |
|---|---|
| Hong Kong: | +852 30186877 |
| Japan: | +81 345899421 |
| Singapore: | +65 31575746 |
| South Africa: | +27 110623033 |
| UK: | +44 2034785524 |
| USA: | +1 3233868721 |
Contact for Clarifications
For any queries related to the earnings call, participants may reach out to the following contacts:
- Diwakar Pingle — Email: Diwakar.Pingle@in.ey.com
- Runjhun Jain — Email: Runjhun.Jain1@in.ey.com | Phone: +91 9820720993
Alivus Life Sciences is headquartered at Technopolis Knowledge Park, A Wing, Office No. 401 to 407, 4th Floor, Mahakali Caves Road, Andheri (E), Mumbai – 400093, with its registered office at Plot No 170-172, Chandramouli Industrial Estate, Mohol Bazarpet, Solapur 413 213, India.
Historical Stock Returns for Alivus Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.02% | +8.01% | +7.84% | +22.54% | +0.21% | +49.81% |
How has the rebranding from Glenmark Life Sciences to Alivus Life Sciences impacted investor sentiment and the company's strategic positioning in the API market?
What revenue growth trajectory and margin expansion can investors expect from Alivus Life Sciences in FY2026-27 given the competitive pressures in the active pharmaceutical ingredients sector?
Will Alivus Life Sciences announce any new licensing agreements, capacity expansions, or geographic diversification plans during the Q4 FY2026 earnings call?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
